ArticleTargeted oncology2024

Comment on: "Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta‑analysis".

Jun Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.